Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer

NCT06572735 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

OTHER: QoL surveys
OTHER: Geriatric assessment (G-CODE)
BIOLOGICAL: Blood sampling

Sponsor

Hospices Civils de Lyon